...
首页> 外文期刊>Clinical Endocrinology >Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis.
【24h】

Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis.

机译:非功能性垂体腺瘤手术治疗的结果:系统评价和荟萃分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Surgery is commonly used in the management of pituitary nonfunctioning adenomas (NFPA). The goal of this systematic review and meta-analysis is to evaluate the effect of surgery on mortality, surgical complications, pituitary function and vision. METHODS: We searched MEDLINE, EMBASE and Cochrane CENTRAL, queried experts and reviewed the reference list of included publications. Eligible studies were comparative and noncomparative longitudinal studies that enroled patients with NFPA who underwent surgery (alone or in combination with other therapies). Reviewers, working independently and in duplicate, determined study eligibility with adequate reproducibility and extracted descriptive, quality and outcome data. Risks, relative risks (RR) and 95% confidence intervals (CIs) were estimated from each study and pooled using random-effects meta-analysis. RESULTS: Most included studies were uncontrolled case series in which patients received a combination of surgery and radiotherapy. The overall quality of the evidence was very low. Median follow-up was 4.29 years. When surgery was not combined with radiotherapy, there was an increased risk of tumour recurrence (RR 1.97; 95% CI, 1.15-3.35). Complications were more likely with the transcranial than with the transsphenoidal approach (mortality RR 4.89; 95% CI, 3.15-6.47; new anterior pituitary deficits RR 4.90; 95% CI, 2.94-7.82; and persistent diabetes insipidus RR 2.50; 95% CI, 1.05-5.35). Overall, transsphenoidal surgery had fairly low perioperative mortality (
机译:背景:外科手术通常用于垂体无功能腺瘤(NFPA)的治疗。该系统评价和荟萃分析的目的是评估手术对死亡率,手术并发症,垂体功能和视力的影响。方法:我们搜索了MEDLINE,EMBASE和Cochrane CENTRAL,询问专家并审查了所包括出版物的参考清单。符合条件的研究是比较性和非比较性纵向研究,这些研究招募了接受手术(单独或与其他疗法组合)的NFPA患者。审稿人独立工作,一式两份,确定了研究资格并具有足够的可重复性,并提取了描述性,质量和结果数据。从每项研究中评估风险,相对风险(RR)和95%置信区间(CIs),并使用随机效应荟萃分析进行汇总。结果:大多数纳入研究均为病例不受控制的病例,其中患者接受了手术和放射疗法的联合治疗。证据的总体质量非常低。中位随访时间为4.29年。当手术不与放疗结合时,肿瘤复发的风险增加(RR 1.97; 95%CI,1.15-3.35)。经颅比经蝶骨入路更容易发生并发症(死亡率RR 4.89; 95%CI,3.15-6.47;新的垂体前叶赤字RR 4.90; 95%CI,2.94-7.82;持续性尿崩症RR 2.50; 95%CI ,1.05-5.35)。总体而言,经蝶骨手术的围手术期死亡率较低(

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号